There are higher levels of alpha-synuclein antibodies in RBD cases at high risk of Parkinson’s disease conversion and B cells are lower in number and more reactive to stimulation in Parkinson’s disease patients at risk of an early dementia. This evidence concerns the gene SNCA and Parkinson disease.